EAM
ALXN
Exane Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-27,078
| Closed | -$3.55M | – | 47 |
|
|
2019
Q2 | $3.55M | Buy |
+27,078
| New | +$3.55M | 1.58% | 20 |
|
|
2019
Q1 | – | Sell |
-14,758
| Closed | -$1.44M | – | 109 |
|
|
2018
Q4 | $1.44M | Sell |
14,758
-123,162
| -89% | -$12M | 0.84% | 23 |
|
|
2018
Q3 | $19.2M | Buy |
+137,920
| New | +$19.2M | 6% | 3 |
|
|
2018
Q2 | – | Sell |
-112,999
| Closed | -$12.6M | – | 181 |
|
|
2018
Q1 | $12.6M | Buy |
+112,999
| New | +$12.6M | 3.78% | 8 |
|
|
2017
Q4 | – | Sell |
-79,865
| Closed | -$11.2M | – | 155 |
|
|
2017
Q3 | $11.2M | Sell |
79,865
-12,908
| -14% | -$1.81M | 2.19% | 17 |
|
|
2017
Q2 | $11.3M | Buy |
+92,773
| New | +$11.3M | 3.52% | 12 |
|
|
2016
Q4 | – | Sell |
-100,933
| Closed | -$12.4M | – | 43 |
|
|
2016
Q3 | $12.4M | Sell |
100,933
-40,521
| -29% | -$4.97M | 3.88% | 9 |
|
|
2016
Q2 | $16.5M | Buy |
+141,454
| New | +$16.5M | 6.41% | 4 |
|